The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

In late June 2026, Recursion Pharmaceuticals, Inc. was added to multiple Russell value and small-cap benchmarks, including the Russell 2000 Value Index, expanding its presence in key equity indices.

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

ARK Invest CEO Cathie Wood reaffirmed her firm’s long-term bullish outlook for Bitcoin, projecting a base case of approximately $750,000 and a bull case of $1,250,000 within the next five years, even ...

Evercore ISI sets a base case S&P 500 target of 7,750 for year-end 2026, with a 30% chance of a bull case reaching 9,000. AI-driven gains in tech, communication services, and consumer discretionary ...

Max Layton, Citi global head of commodities research, joins 'Squawk Box' to discuss the impact of the Iran war on the energy market, what the best/worst case scenarios for the oil market are, and more ...

LONDON, March 6 (Reuters Breakingviews) - What endgame for Iran are investors pricing in? Judging by moves in financial markets since U.S. President Donald Trump and Israeli Prime Minister Benjamin ...

Federal Reserve Bank of Cleveland President Beth Hammack said monetary policy is in a good place to pause and assess the effects of 75 basis points of rate cuts in the economy during the first quarter ...

Citigroup's base case for bitcoin (BTC) is a rise to $143,000 in 12 months. Analysts highlight $70,000 as key support, with the potential for a sharp rise due to revived ETF demand and positive market ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...